270 related articles for article (PubMed ID: 12756622)
21. Immunologic mechanisms in the pathogenesis of virus-induced leukemia. IV. Mechanism of target cell recognition by autoreactive thymocytes.
Proffitt MR; Kozak C; de la Motte C; Caulfield MJ
J Immunol; 1985 Jun; 134(6):4244-9. PubMed ID: 3872912
[TBL] [Abstract][Full Text] [Related]
22. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor.
Kim JW; Closs EI; Albritton LM; Cunningham JM
Nature; 1991 Aug; 352(6337):725-8. PubMed ID: 1652100
[TBL] [Abstract][Full Text] [Related]
23. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
[TBL] [Abstract][Full Text] [Related]
24. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
Burkhart MD; Kayman SC; He Y; Pinter A
J Virol; 2003 Apr; 77(7):3993-4003. PubMed ID: 12634359
[TBL] [Abstract][Full Text] [Related]
25. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Morling FJ; Peng KW; Cosset FL; Russell SJ
Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
[TBL] [Abstract][Full Text] [Related]
26. Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene.
Jackson MK; Mitchell EA; Winslow SG; Okelberry KM; Sidwell RW; Morrey JD
Acta Virol; 1999 Feb; 43(1):19-23. PubMed ID: 10672339
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
[TBL] [Abstract][Full Text] [Related]
28. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway.
Lee S; Zhao Y; Anderson WF
J Virol; 1999 Jul; 73(7):5994-6005. PubMed ID: 10364351
[TBL] [Abstract][Full Text] [Related]
30. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein.
Ishihara C; Miyazawa M; Nishio J; Chesebro B
J Immunol; 1991 Jun; 146(11):3958-63. PubMed ID: 2033265
[TBL] [Abstract][Full Text] [Related]
31. Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.
Choppin J; Schaffar-Deshayes L; Debré P; Lévy JP
J Immunol; 1981 Jun; 126(6):2347-51. PubMed ID: 7229379
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
33. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
34. A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.
Zavorotinskaya T; Albritton LM
J Virol; 1999 Dec; 73(12):10164-72. PubMed ID: 10559332
[TBL] [Abstract][Full Text] [Related]
35. Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection.
Ikeda H; Odaka T
Virology; 1983 Jul; 128(1):127-39. PubMed ID: 6192586
[TBL] [Abstract][Full Text] [Related]
36. Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.
Jobbagy Z; Garfield S; Baptiste L; Eiden MV; Anderson WB
J Virol; 2000 Mar; 74(6):2847-54. PubMed ID: 10684301
[TBL] [Abstract][Full Text] [Related]
37. Receptor-binding domain of murine leukemia virus envelope glycoproteins.
Battini JL; Danos O; Heard JM
J Virol; 1995 Feb; 69(2):713-9. PubMed ID: 7815534
[TBL] [Abstract][Full Text] [Related]
38. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor.
Heard JM; Danos O
J Virol; 1991 Aug; 65(8):4026-32. PubMed ID: 2072445
[TBL] [Abstract][Full Text] [Related]
39. The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain.
Rey MA; Prasad R; Tailor CS
Virology; 2008 Jan; 370(2):273-84. PubMed ID: 17945326
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
